医療従事者の為の最新医療ニュースや様々な情報・ツールを提供する医療総合サイト

To Combat Coronavirus, iFLYTEK Receives License from the U.S. Department of Commerce

2020年03月04日 AM12:48
このエントリーをはてなブックマークに追加


 

HEFEI, China

iFLYTEK, Asia’s leading artificial intelligence (AI) and speech technology company, has received an export license from the U.S. Department of Commerce to purchase medical supplies to help combat the coronavirus. Specifically, the license will enable iFLYTEK to procure basic medical supplies, including protective coveralls, surgical masks, protective eyewear, and digital thermometers.

“Since the initial outbreak of the coronavirus, iFLYTEK has mobilized its global partner network to help collect medical supplies to support the epidemic’s control and prevention campaign,” said iFLYTEK Chief Financial Officer Mr. Dawei Duan. “We are pleased that the U.S. granted this license so that we can continue to fight on the front lines against this critical global health issue.”

In addition to leveraging its global network for medical supplies, iFLYTEK has donated 10 million yuan (approximately $1.44 million) of its own AI technology and equipment to prevent the further spread of the illness. iFLYTEK’s donations include the deployment of its intelligent medical assistants to 66 districts and counties to help physicians screen high-risk patients.

iFLYTEK has donated more than 12,000 protective masks, 3,000 protective suits, and 13,000 pairs of goggles to hospitals in the Hubei Province, including Zhongnan Hospital of Wuhan University and the Third People’s Hospital of Wuhan City to help alleviate the limited supply of medical materials. iFLYTEK has also provided its smart online classroom to primary and secondary schools in Hubei province at no cost and has dedicated 29 full-time personnel to the prevention and control of the coronavirus in Anhui.

“iFLYTEK continues to support and advocate for extensive international cooperation to help fight the coronavirus. We will continue to devote our time to help create a better world in the spirit of humanitarianism with artificial intelligence,” said Duan.

iFLYTEK employs artificial intelligence technologies and products to help primary medical institutions diagnose patients through the intelligent medical assistant and to assist relevant agencies and partners in carrying out epidemic prevention and control, follow-up visits, and communications.

View source version on businesswire.com: https://www.businesswire.com/news/home/20200303005707/en/

CONTACT

Alyse LaVoie, 202-600-4741

Related Posts Plugin for WordPress, Blogger...

同じカテゴリーの記事 

  • 印尼生命科学与技术学院在NCRM NICHE 2021上赢得第16届Fujio Cup Quiz大赛;印度Rajalakshmi工程学院获得亚军
  • 辉凌将在ACG 2021上展示基于微生物群的在研活体生物治疗药物RBX2660用于治疗艰难梭菌反复感染和IBD患者的获奖真实临床转归分析
  • ShouTi Secures $100 Million Series B Financing to Accelerate Development of Life-Changing Medicines Fueled by Advanced Computational, Structure-Based Drug Design Platform
  • 硕迪B轮成功融资1亿美元,利用先进的计算和结构药物设计平台加速开发改变患者命运的药物
  • CANbridge Pharmaceuticals CAN103 Investigational New Drug Application Approved in China for Treatment of Gaucher Disease